I want to donate

The Neurodevelopmental disorders research group focuses on the problems experienced by children and adults who have intellectual disabilities, borderline intellectual disorders, autism spectrum disorders and genetic syndromes related to development.

The multidisciplinary team composed of psychiatrists, psychologists, nurses, social workers, and graduate students, conducts high-quality research on mental, cognitive, and behavioural disorders in children and adults with neurological development disorders. We transfer the results of the research to both evaluational and interventional clinical practice. This allows us to offer information, advice and support to parents, caregivers, and professionals.

Main lines of research
  • Aging, mild cognitive deterioration, and dementia in people with intellectual disability.
  • Genetics in mental illness and challenging behaviour in people with intellectual disability
  • Behavioural and neuropsychological phenotypes of genetic origin
  • Autism and neuropsychology
  • Comprehensive attention to people with Borderline Intellectual Disorders
Strategic objectives
  • To be a reference group in research and teaching in neurodevelopmental disorders (NDD) (IDD, BID, ASD, among others).
  • Consolidating clinical research into Neurodegenerative Disorders in people with NDDs
  • Consolidating genetic and clinical research into Cognitive-Behavioural Phenotypes
  • To be a reference group in developing evaluation tests and cognitive intervention in NDDs
  • To be a reference group in the comprehensive (bio-psycho-social) care model for people with NDDs
  • Establishing research collaborations with national and international groups in the field of NDDs

Esteba-Castillo S, Garcia-Alba J, Rodríguez-Hildago E, Vaquero L, Novell R, Moldenhauer F, Castellanos MÁ

Proposed diagnostic criteria for mild cognitive impairment in Down syndrome population.


Social Responsiveness and Psychosocial Functioning in Adults with Prader-Willi Syndrome.

Journal of Clinical Medicine, 2022, 11

Caixàs A, Blanco-Hinojo L, Pujol J, Deus J, Giménez-Palop O, Torrents-Rodas D, Coronas R, Novell R, Esteba-Castillo S

Altered Gesture Imitation and Brain Anatomy in Adult Prader-Willi Syndrome Patients.


Ramírez Toraño F, García Alba J, Bruña R, Esteba Castillo S, Vaquero L, Pereda E, Maestu F, Fernández A

Hypersynchronized MEG brain networks in patients with mild cognitive impairment and Alzheimer's disease in Down syndrome.

Brain Connectivity, 2021, 11, 725-733

Torres-Pascual, Cristina, Sanchez-Perez, Hector Javier, Avila-Castells, Pilar

Geographical distribution and international collaboration of Latin American and Caribbean scientific publications on tuberculosis in Pubmed.

Revista Peruana de Medicina Experimental y Salud Publica, 2021, 38, 49-57

Cobo J, Coronas R, Pousa E, Oliva JC, Giménez-Palop O, Esteba-Castillo S, Novell R, Palao DJ, Caixàs A

Multidimensional Evaluation of Awareness in Prader-Willi Syndrome.

Journal of Clinical Medicine, 2021, 10

Blanco-Hinojo L, Casamitjana L, Pujol J, Martínez-Vilavella G, Esteba-Castillo S, Giménez-Palop O, Freijo V, Deus J, Caixàs A

Cerebellar Dysfunction in Adults with Prader Willi Syndrome.

Journal of Clinical Medicine, 2021, 10

Giménez-Palop O, Casamitjana L, Corripio R, Esteba-Castillo S, Pareja R, Albiñana N, Rigla M, Caixàs A

Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader-Willi Syndrome.

Journal of Clinical Medicine, 2021, 10

Bueno M, Boixadera-Planas E, Blanco-Hinojo L, Esteba-Castillo S, Giménez-Palop O, Torrents-Rodas D, Pujol J, Corripio R, Deus J, Caixàs A

Hunger and Satiety Peptides: Is There a Pattern to Classify Patients with Prader-Willi Syndrome?

Journal of Clinical Medicine, 2021, 10

de la Torre R, de Sola S, Farré M, Xicota L, Cuenca-Royo A, Rodriguez J, León A, Langohr K, Gomis-González M, Hernandez G, Esteba S, Del Hoyo L, Sánchez-Gutiérrez J, Cortés MJ, Ozaita A, Espadaler JM, Novell R, Martínez-Leal R, Milá M, Dierssen M

A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome.

CLINICAL NUTRITION, 2020, 39, 378-387
Competitive projects
Codi oficial: KA202-86149EDA Start date:01/03/2022 Data fi: 31/08/2024 Investigador/a principal: LAURA VERGES PLANAGUMA Organisme finançador: EUROPEAN COMISSION Ajuda: 0 €
Job offers


Group leader - R4

Established researchers - R3

Postdoctorals researchers – R2

Predoctorals researchers – R1


Research technicians

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in